Illumina, Inc. (ILMN) recently unveiled the DRAGEN version 4.4 software (v4.4), the industry's most comprehensive secondary analysis solution. The latest version includes out-of-the-box oncology applications for clinical research, greater accuracy and support for the company’s newly announced multiomics assays.The DRAGEN v4.4 enhancements are expected to simplify NGS analysis for customers while expanding their capabilities. The University Hospital of Tübingen in Germany is among the first adopters of the l ...